Al-Bilad Medical Services Co. operates a general hospital to provide health, preventive, diagnostic, and therapeutic services in Jordan.
Price History & Performance
|Historical stock prices|
|Current Share Price||د.أ0.81|
|52 Week High||د.أ0.55|
|52 Week Low||د.أ0.81|
|1 Month Change||3.85%|
|3 Month Change||15.71%|
|1 Year Change||42.11%|
|3 Year Change||-10.00%|
|5 Year Change||-14.74%|
|Change since IPO||-29.95%|
Recent News & Updates
|ABMS||JO Healthcare||JO Market|
Return vs Industry: ABMS exceeded the JO Healthcare industry which returned 4.9% over the past year.
Return vs Market: ABMS exceeded the JO Market which returned 36.5% over the past year.
Stable Share Price: Insufficient data to determine ABMS's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine ABMS's volatility change over the past year.
About the Company
|1996||607||Ahmad Mohammed Al-Ahmad||https://istiklal.jo|
Al-Bilad Medical Services Co. operates a general hospital to provide health, preventive, diagnostic, and therapeutic services in Jordan. The company also provides financial brokerage services. Al-Bilad Medical Services Co. was founded in 1996 and is based in Amman, Jordan.
Al-Bilad Medical Services Fundamentals Summary
|ABMS fundamental statistics|
Is ABMS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ABMS income statement (TTM)|
|Cost of Revenue||د.أ9.64m|
Last Reported Earnings
Dec 31, 2020
Next Earnings Date
|Earnings per share (EPS)||0.018|
|Net Profit Margin||3.91%|
How did ABMS perform over the long term?See historical performance and comparison
Is Al-Bilad Medical Services undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate ABMS's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate ABMS's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: ABMS is poor value based on its PE Ratio (46x) compared to the Asian Healthcare industry average (24.7x).
PE vs Market: ABMS is poor value based on its PE Ratio (46x) compared to the JO market (13.3x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ABMS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ABMS is good value based on its PB Ratio (0.9x) compared to the XA Healthcare industry average (2.3x).
How is Al-Bilad Medical Services forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Al-Bilad Medical Services has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Al-Bilad Medical Services performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ABMS has high quality earnings.
Growing Profit Margin: ABMS's current net profit margins (3.9%) are higher than last year (0.8%).
Past Earnings Growth Analysis
Earnings Trend: ABMS has become profitable over the past 5 years, growing earnings by 5.7% per year.
Accelerating Growth: ABMS's earnings growth over the past year (399.6%) exceeds its 5-year average (5.7% per year).
Earnings vs Industry: ABMS earnings growth over the past year (399.6%) exceeded the Healthcare industry 34.1%.
Return on Equity
High ROE: ABMS's Return on Equity (2%) is considered low.
How is Al-Bilad Medical Services's financial position?
Financial Position Analysis
Short Term Liabilities: ABMS's short term assets (JOD12.5M) exceed its short term liabilities (JOD1.7M).
Long Term Liabilities: ABMS's short term assets (JOD12.5M) exceed its long term liabilities (JOD7.4M).
Debt to Equity History and Analysis
Debt Level: ABMS's debt to equity ratio (3.9%) is considered satisfactory.
Reducing Debt: ABMS's debt to equity ratio has reduced from 12.9% to 3.9% over the past 5 years.
Debt Coverage: ABMS's debt is well covered by operating cash flow (90.8%).
Interest Coverage: ABMS's interest payments on its debt are not well covered by EBIT (2.4x coverage).
What is Al-Bilad Medical Services's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ABMS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ABMS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ABMS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ABMS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ABMS is not paying a notable dividend for the JO market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ABMS's dividend in 3 years as they are not forecast to pay a notable one for the JO market.
How experienced are the management team and are they aligned to shareholders interests?
Ahmad Mohammed Al-Ahmad (37 yo)
Mr. Ahmad Mohammed Mahmoud Al-Ahmad serves as General Manager at Al-Bilad Medical Services Co. and served as its Internal Audit Manager since January 26, 2015. Mr. Al-Ahmad has been a Representative Direct...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Ahmad Mohammed's total compensation is reasonable compared to companies of similar size in the JO market.
Compensation vs Earnings: Insufficient data to compare Ahmad Mohammed's compensation with company performance.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Al-Bilad Medical Services Co.'s employee growth, exchange listings and data sources
- Name: Al-Bilad Medical Services Co.
- Ticker: ABMS
- Exchange: ASE
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: د.أ24.300m
- Shares outstanding: 30.00m
- Website: https://istiklal.jo
Number of Employees
- Al-Bilad Medical Services Co.
- PO Box 1493
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/17 11:31|
|End of Day Share Price||2021/09/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.